Inhibitor Therapeutics (INTI) Current Assets (2012 - 2026)
Inhibitor Therapeutics (INTI) reported Current Assets of $586,806 for Q2 2026, down 84.7% from $3.83 million a year earlier and down 57.4% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics posted Current Assets of $2.45 million, down 57.0% from FY2024.
- Current Assets has declined for three consecutive years, though with a five-year compound annual growth rate of 86.9% (FY2020 to FY2025).
- By year, Current Assets came in at $5.69 million in FY2024 (-36.4%), $8.95 million in FY2023 (-25.3%), $11.98 million in FY2022 and $58,784 in FY2021 (-45.2%).
- The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q3 2022.
- Year over year, Current Assets has now declined in each of the last 11 quarters, with an average decline of 52.8% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q3 2021 (growth of 25.1%); the low point was Q2 2026 (a decline of 84.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.38 million (Q1 2026), $2.45 million (Q4 2025) and $3.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 586,806.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 586,806.00 |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 5.69 Mn |
| Sep 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 7.17 Mn |
| Mar 31, 2024 | 7.79 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Sep 30, 2023 | 9.61 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 10.84 Mn |
| Dec 31, 2022 | 11.98 Mn |
| Sep 30, 2022 | 63,117.00 |
| Jun 30, 2022 | 38,517.00 |
| Mar 31, 2022 | 61,143.00 |
| Dec 31, 2021 | 58,784.00 |
| Sep 30, 2021 | 90,079.00 |
API Access
Inhibitor Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();